Αλλαντική τοξίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Αλλαντική τοξίνη" in Greek language version.

refsWebsite

Global rank Greek rank

63nih.gov

4^th place

46doi.org

2^nd place

3^rd place

10archive.org

6^th place

5^th place

8web.archive.org

1^st place

7fda.gov

447^th place

368^th place

3cdc.gov

218^th place

156^th place

2harvard.edu

18^th place

57^th place

2cnn.com

28^th place

93^rd place

2medscape.com

719^th place

579^th place

1drugs.com

399^th place

130^th place

1who.int

195^th place

72^nd place

1medicaldaily.com

low place

7,691^st place

1actavis.com

low place

1mayoclinic.org

1,610^th place

485^th place

1jaoa.org

low place

1dddmag.com

low place

1webmd.com

1,169^th place

603^rd place

1cbc.ca

115^th place

503^rd place

1nytimes.com

7^th place

29^th place

1shareholder.com

6,233^rd place

2,641^st place

1washingtonpost.com

34^th place

118^th place

1companiesandmarkets.com

low place

1phac-aspc.gc.ca

low place

1emsworld.com

low place

1allergan.com

low place

1btxa.com

low place

1miinews.com

low place

1botox.com

low place

1springer.com

274^th place

297^th place

actavis.com

«Actavis plc is now Allergan plc». Allergan. 15 Ιουνίου 2015. Αρχειοθετήθηκε από το πρωτότυπο στις 5 Μαΐου 2016. Ανακτήθηκε στις 16 Ιουνίου 2015.

allergan.com

«2011 Allergan Annual Report» (PDF). Allergan. Ανακτήθηκε στις 3 Μαΐου 2012. See PDF p. 7.

archive.org

«Botulinum toxin and sweating». Journal of Neurology, Neurosurgery, and Psychiatry 57 (11): 1437–38. November 1994. doi:10.1136/jnnp.57.11.1437. PMID 7964832. PMC 1073208. https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1994-11_57_11/page/1437.
«Hyperhidrosis: evolving therapies for a well-established phenomenon». Mayo Clinic Proceedings 80 (5): 657–66. May 2005. doi:10.4065/80.5.657. PMID 15887434. https://archive.org/details/sim_mayo-clinic-proceedings_2005-05_80_5/page/657.
«Diagnostic injection of Xylocaine into extraocular muscles». Ophthalmology 89 (5): 489–91. May 1982. doi:10.1016/s0161-6420(82)34764-8. PMID 7099568. https://archive.org/details/sim_ophthalmology_1982-05_89_5/page/489.
«Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery». Ophthalmology 87 (10): 1044–49. October 1980. doi:10.1016/s0161-6420(80)35127-0. PMID 7243198. https://archive.org/details/sim_ophthalmology_1980-10_87_10/page/1044.
Baselt RC (2014). Disposition of toxic drugs and chemicals in man. Seal Beach, Ca.: Biomedical Publications. σελίδες 260–61. ISBN 978-0-9626523-9-4.
Jay, James M.· Loessner, Martin J. (2005). «Chapter 24: Food Poisoning Caused by Gram-Positive Sporeforming Bacteria». Modern Food Microbiology: Seventh Edition. New York: Springer. σελ. 581. ISBN 978-0-387-23180-8.
«Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins». Toxicon 54 (5): 575–82. October 2009. doi:10.1016/j.toxicon.2009.03.016. PMID 19327377. PMC 2730986. https://archive.org/details/sim_toxicon_2009-10_54_5/page/575.
«Injection of type A botulinum toxin into extraocular muscles for correction of strabismus». Canadian Journal of Ophthalmology 22 (4): 212–17. June 1987. PMID 3607594. https://archive.org/details/sim_canadian-journal-of-ophthalmology_1987-06_22_4/page/212.
Giesler, Markus (2012). «How Doppelgänger Brand Images Influence the Market Creation Process: Longitudinal Insights from the Rise of Botox Cosmetic». Journal of Marketing 76 (6): 55–68. doi:10.1509/jm.10.0406. https://archive.org/details/sim_journal-of-marketing_2012-11_76_6/page/55.
«OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program». Headache 50 (6): 921–36. June 2010. doi:10.1111/j.1526-4610.2010.01678.x. PMID 20487038. https://archive.org/details/sim_headache_2010-06_50_6/page/921.

botox.com

«BOTOX Cosmetic (onabotulinumtoxinA) Product Information». Allergan. 22 Ιανουαρίου 2014.

btxa.com

«Botulinum Toxin Type A». Hugh Source (International) Limited. Ανακτήθηκε στις 14 Ιουλίου 2010.

cbc.ca

«Botox chemical may spread, Health Canada confirms». CBC News. January 13, 2009. Αρχειοθετήθηκε από το πρωτότυπο στις 21 February 2009. https://web.archive.org/web/20090221144310/http://www.cbc.ca/consumer/story/2009/01/13/botox.html.

cdc.gov

«Kinds of Botulism». Centers for Disease Control and Prevention. Ανακτήθηκε στις 4 Οκτωβρίου 2016.
«Botulism – Diagnosis and Treatment». Centers for Disease Control and Prevention. Ανακτήθηκε στις 5 Οκτωβρίου 2016.
Botulism, Γενικές Πληροφορίες - NCZVED. Cdc.gov. Ανακτήθηκε στις 6 Μαΐου 2012.

cnn.com

money.cnn.com

Egan, Matt (17 Νοεμβρίου 2014). «Botox maker bought for $66 billion in biggest deal of 2014». cnn.com.

us.cnn.com

Watkins, Tom (October 15, 2010). «FDA approves Botox as migraine preventative». CNN (US). Αρχειοθετήθηκε από το πρωτότυπο στις 2020-07-27. https://web.archive.org/web/20200727025543/http://us.cnn.com/2010/HEALTH/10/15/migraines.botox/index.html. Ανακτήθηκε στις 2019-04-10.

companiesandmarkets.com

Chapman, Paul (10 Μαΐου 2012). «The global botox market forecast to reach $2.9 billion by 2018». Αρχειοθετήθηκε από το πρωτότυπο στις 6 Αυγούστου 2012. Ανακτήθηκε στις 5 Οκτωβρίου 2012.

dddmag.com

UK Approves New Botox Use Σφάλμα στο πρότυπο webarchive: Ελέγξτε την τιμή |url=. Empty.. dddmag.com. February 4, 2014

doi.org

dx.doi.org

«Botulinal neurotoxins: revival of an old killer». Current Opinion in Pharmacology 5 (3): 274–79. June 2005. doi:10.1016/j.coph.2004.12.006. PMID 15907915.
Figgitt, David P.; Noble, Stuart (2002). «Botulinum Toxin B». Drugs 62 (4): 705–722. doi:10.2165/00003495-200262040-00011. PMID 11893235.
«Botulinum toxin as a biological weapon: medical and public health management». JAMA 285 (8): 1059–70. February 2001. doi:10.1001/jama.285.8.1059. PMID 11209178.
«Clostridium botulinum: a bug with beauty and weapon». Critical Reviews in Microbiology 31 (1): 11–18. 2005. doi:10.1080/10408410590912952. PMID 15839401.
«Botox treatment for vaginismus». Plastic and Reconstructive Surgery 124 (6): 455e–56e. December 2009. doi:10.1097/PRS.0b013e3181bf7f11. PMID 19952618.
«Endoscopic approaches to treatment of achalasia». Therapeutic Advances in Gastroenterology 6 (2): 115–35. March 2013. doi:10.1177/1756283X12468039. PMID 23503707.
«Efficacy of botulinum toxins on bruxism: an evidence-based review». International Dental Journal 62 (1): 1–5. February 2012. doi:10.1111/j.1875-595X.2011.00085.x. PMID 22251031.
«Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)». European Urology 60 (4): 784–95. October 2011. doi:10.1016/j.eururo.2011.07.001. PMID 21782318.
«Injections of botulinum A toxin for the treatment of anal fissures». The European Journal of Surgery = Acta Chirurgica 168 (12): 720–23. 2002. doi:10.1080/11024150201680030. PMID 15362583.
«Botulinum toxin in the treatment of strabismus. A review of its use and effects». Disability and Rehabilitation 29 (23): 1823–31. December 2007. doi:10.1080/09638280701568189. PMID 18033607.
«Botulinum toxin injections for adults with overactive bladder syndrome». The Cochrane Database of Systematic Reviews (12): CD005493. December 2011. doi:10.1002/14651858.CD005493.pub3. PMID 22161392.
«Botulinum toxin and sweating». Journal of Neurology, Neurosurgery, and Psychiatry 57 (11): 1437–38. November 1994. doi:10.1136/jnnp.57.11.1437. PMID 7964832. PMC 1073208. https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1994-11_57_11/page/1437.
«Hyperhidrosis: evolving therapies for a well-established phenomenon». Mayo Clinic Proceedings 80 (5): 657–66. May 2005. doi:10.4065/80.5.657. PMID 15887434. https://archive.org/details/sim_mayo-clinic-proceedings_2005-05_80_5/page/657.
«Botulinum Toxin Treatment of Neuropathic Pain». Seminars in Neurology 36 (1): 73–83. February 2016. doi:10.1055/s-0036-1571953. PMID 26866499.
«Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses». American Journal of Health-System Pharmacy 61 (22 Suppl 6): S11–23. November 2004. doi:10.1093/ajhp/61.suppl_6.S11. PMID 15598005.
«Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases». Journal of the American Academy of Dermatology 53 (3): 407–15. September 2005. doi:10.1016/j.jaad.2005.06.011. PMID 16112345.
«Botulinum neurotoxin detection and differentiation by mass spectrometry». Emerging Infectious Diseases 11 (10): 1578–83. October 2005. doi:10.3201/eid1110.041279. PMID 16318699.
Dressler, D; Saberi, FA; Barbosa, ER (March 2005). «Botulinum toxin: mechanisms of action.». Arquivos de Neuro-Psiquiatria 63 (1): 180–5. doi:10.1159/000083259. PMID 15830090.
«Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication». Molecules 16 (1): 202–20. December 2010. doi:10.3390/molecules16010202. PMID 21193845.
«Historical aspects of botulinum toxin: Justinus Kerner (1786–1862) and the "sausage poison"». Neurology 53 (8): 1850–53. November 1999. doi:10.1212/wnl.53.8.1850. PMID 10563638.
«Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as "Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus" in Zeitschrift für Hygiene und Infektionskrankheiten 26: 1–56, 1897» (στα German). Reviews of Infectious Diseases 1 (4): 701–19. 1979. PMID 399378. Original
doi:10.1007/BF02220526
Snipe, P. Tessmer; Sommer, H. (August 1928). «Studies on Botulinus Toxin: 3. Acid Precipitation of Botulinus Toxin». The Journal of Infectious Diseases 43 (2): 152–60. doi:10.1093/infdis/43.2.152.
«The purification and crystallization of Clostridium botulinum type A toxin». Science 103 (2681): 613–14. May 1946. doi:10.1126/science.103.2681.613. PMID 21026141. Bibcode: 1946Sci...103..613L.
«The action of botulinum toxin on the neuro-muscular junction». The Journal of Physiology 109 (1–2): 10–24. August 1949. doi:10.1113/jphysiol.1949.sp004364. PMID 15394302.
«Diagnostic injection of Xylocaine into extraocular muscles». Ophthalmology 89 (5): 489–91. May 1982. doi:10.1016/s0161-6420(82)34764-8. PMID 7099568. https://archive.org/details/sim_ophthalmology_1982-05_89_5/page/489.
«Atrophy of skeletal muscle in chick embryos treated with botulinum toxin». Science 145 (3633): 719–21. August 1964. doi:10.1126/science.145.3633.719. PMID 14163805. Bibcode: 1964Sci...145..719D.
«Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery». Ophthalmology 87 (10): 1044–49. October 1980. doi:10.1016/s0161-6420(80)35127-0. PMID 7243198. https://archive.org/details/sim_ophthalmology_1980-10_87_10/page/1044.
«The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?». Health Policy 95 (2–3): 216–28. May 2010. doi:10.1016/j.healthpol.2009.12.001. PMID 20036435.
«Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis». Plastic and Reconstructive Surgery 84 (2): 353–55. August 1989. doi:10.1097/01.prs.0000205566.47797.8d. PMID 2748749.
«Treatment of glabellar frown lines with C. botulinum-A exotoxin». The Journal of Dermatologic Surgery and Oncology 18 (1): 17–21. January 1992. doi:10.1111/j.1524-4725.1992.tb03295.x. PMID 1740562.
«Botulinum toxin A: a novel method to remove periorbital wrinkles». Facial Plastic Surgery 10 (2): 141–46. April 1994. doi:10.1055/s-2008-1064563. PMID 7995530.
«Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study». Otolaryngology–Head and Neck Surgery 123 (6): 669–76. December 2000. doi:10.1067/mhn.2000.110960. PMID 11112955.
«Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis». JAMA 307 (16): 1736–45. April 2012. doi:10.1001/jama.2012.505. PMID 22535858.
«Therapeutic use of botulinum toxin in migraine: mechanisms of action». British Journal of Pharmacology 171 (18): 4177–92. September 2014. doi:10.1111/bph.12763. PMID 24819339.
«I will survive: DNA protection in bacterial spores». Trends in Microbiology 15 (4): 172–80. April 2007. doi:10.1016/j.tim.2007.02.004. PMID 17336071.
«Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins». Toxicon 54 (5): 575–82. October 2009. doi:10.1016/j.toxicon.2009.03.016. PMID 19327377. PMC 2730986. https://archive.org/details/sim_toxicon_2009-10_54_5/page/575.
«Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology». Ophthalmology Suppl: 37–41. September 1989. doi:10.1016/s0161-6420(89)32989-7. PMID 2779991.
Giesler, Markus (2012). «How Doppelgänger Brand Images Influence the Market Creation Process: Longitudinal Insights from the Rise of Botox Cosmetic». Journal of Marketing 76 (6): 55–68. doi:10.1509/jm.10.0406. https://archive.org/details/sim_journal-of-marketing_2012-11_76_6/page/55.
«BOTOX: Broadening the Horizon of Dentistry». Journal of Clinical and Diagnostic Research : JCDR 8 (12): ZE25–9. December 2014. doi:10.7860/JCDR/2014/11624.5341. PMID 25654058.
«Botulinum Toxin for the Treatment of Gummv Smile». The Journal of Contemporary Dental Practice 18 (6): 474–478. June 2017. doi:10.5005/jp-journals-10024-2068. PMID 28621277.
«Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin». The Angle Orthodontist 79 (1): 70–7. January 2009. doi:10.2319/091407-437.1. PMID 19123705.
«Botox and the gummy smile». Progress in Orthodontics 11 (1): 76–82. May 2010. doi:10.1016/j.pio.2010.04.004. PMID 20529632.
«Gummy smile and botulinum toxin: a new approach based on the gingival exposure area». Journal of the American Academy of Dermatology 63 (6): 1042–51. December 2010. doi:10.1016/j.jaad.2010.02.053. PMID 21093661.
«OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program». Headache 50 (6): 921–36. June 2010. doi:10.1111/j.1526-4610.2010.01678.x. PMID 20487038. https://archive.org/details/sim_headache_2010-06_50_6/page/921.
«Botulinum toxin type a for chronic migraine». Current Neurology and Neuroscience Reports 10 (2): 140–46. March 2010. doi:10.1007/s11910-010-0087-5. PMID 20425239.
«Neurotoxins: Expanding Uses of Neuromodulators in Medicine – Major Depressive Disorder». Plastic and Reconstructive Surgery 136 (5 Suppl): 111S–19S. November 2015. doi:10.1097/PRS.0000000000001733. PMID 26441090.

drugs.com

American Society of Health-System Pharmacists (27 Οκτωβρίου 2011). «Botulinum Toxin Type A». drugs.com. Ανακτήθηκε στις 4 Μαρτίου 2015.

emsworld.com

«Αρχειοθετημένο αντίγραφο». Αρχειοθετήθηκε από το πρωτότυπο στις 18 Ιουνίου 2017. Ανακτήθηκε στις 10 Απριλίου 2019.

fda.gov

«FDA Notifies Public of Adverse Reactions Linked to Botox Use». Fda.gov. 8 Φεβρουαρίου 2008. Ανακτήθηκε στις 6 Μαΐου 2012.
«FDA Gives Update on Botulinum Toxin Safety Warnings; Established Names of Drugs Changed». FDA Press Announcement. 3 Αυγούστου 2009. Ανακτήθηκε στις 21 Σεπτεμβρίου 2016.
«Information for Healthcare Professionals: OnabotulinumtoxinA (marketed as Botox/Botox Cosmetic), AbobotulinumtoxinA (marketed as Dysport) and RimabotulinumtoxinB (marketed as Myobloc)». fda.gov. Food and Drug Administration. Ανακτήθηκε στις 1 Σεπτεμβρίου 2015.
United States Department of Health and Human Services (30 Απριλίου 2009). «Re: Docket No. FDA-2008-P-0061» (PDF). Food and Drug Administration. Ανακτήθηκε στις 26 Ιουλίου 2010.
«Botulinum Toxin Type A Product Approval Information – Licensing Action 4/12/02». Food and Drug Administration. 29 Οκτωβρίου 2009. Ανακτήθηκε στις 26 Ιουλίου 2010.
Walsh, Sandy (October 15, 2010). «FDA approves Botox to treat chronic migraine». FDA Press Releases. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229782.htm. Ανακτήθηκε στις October 15, 2010.

accessdata.fda.gov

«FDA Approved Drug Products – Dysport». www.accessdata.fda.gov. U.S. Food and Drug Administration. Ανακτήθηκε στις 7 Νοεμβρίου 2016.

harvard.edu

adsabs.harvard.edu

«The purification and crystallization of Clostridium botulinum type A toxin». Science 103 (2681): 613–14. May 1946. doi:10.1126/science.103.2681.613. PMID 21026141. Bibcode: 1946Sci...103..613L.
«Atrophy of skeletal muscle in chick embryos treated with botulinum toxin». Science 145 (3633): 719–21. August 1964. doi:10.1126/science.145.3633.719. PMID 14163805. Bibcode: 1964Sci...145..719D.

jaoa.org

«Botulinum toxin in primary care medicine». The Journal of the American Osteopathic Association 106 (10): 609–14. October 2006. PMID 17122031. http://jaoa.org/article.aspx?articleid=2093199.

mayoclinic.org

«Cervical dystonia». Mayo Clinic. 28 Ιανουαρίου 2014. Ανακτήθηκε στις 14 Οκτωβρίου 2015.

medicaldaily.com

Weller, Chris (15 Οκτωβρίου 2013). «New Botulinum Toxin Deemed Deadliest Substance Ever: Sniffing 13-Billionths of a Gram Can Kill». Medical Daily.

medscape.com

emedicine.medscape.com

Ocampo, Vicente Victor D· Foster, C Stephen (30 Μαΐου 2012). «Infantile Esotropia Treatment & Management». Medscape. Ανακτήθηκε στις 6 Απριλίου 2014.

medscape.com

Koirala, Janak· Basnet, Sangita (14 Ιουλίου 2004). «Botulism, Botulinum Toxin, and Bioterrorism: Review and Update». Medscape. Cliggott Publishing. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Ιουνίου 2011. Ανακτήθηκε στις 14 Ιουλίου 2010.

miinews.com

Petrou, Ilya (Spring 2009). «Medy-Tox Introduces Neuronox to the Botulinum Toxin Arena» (PDF). The European Aesthetic Guide. Αρχειοθετήθηκε από το πρωτότυπο στις 2013-03-20. https://web.archive.org/web/20130320010107/http://www.miinews.com/pdf/MedyTox_Ed_EAGsp09v2_022809.pdf#. Ανακτήθηκε στις 2009-12-09.

nih.gov

ncbi.nlm.nih.gov

«Botulinal neurotoxins: revival of an old killer». Current Opinion in Pharmacology 5 (3): 274–79. June 2005. doi:10.1016/j.coph.2004.12.006. PMID 15907915.
Figgitt, David P.; Noble, Stuart (2002). «Botulinum Toxin B». Drugs 62 (4): 705–722. doi:10.2165/00003495-200262040-00011. PMID 11893235.
«Botulinum toxin as a biological weapon: medical and public health management». JAMA 285 (8): 1059–70. February 2001. doi:10.1001/jama.285.8.1059. PMID 11209178.
«Clostridium botulinum: a bug with beauty and weapon». Critical Reviews in Microbiology 31 (1): 11–18. 2005. doi:10.1080/10408410590912952. PMID 15839401.
«Botox treatment for vaginismus». Plastic and Reconstructive Surgery 124 (6): 455e–56e. December 2009. doi:10.1097/PRS.0b013e3181bf7f11. PMID 19952618.
«Botulinum toxin in primary care medicine». The Journal of the American Osteopathic Association 106 (10): 609–14. October 2006. PMID 17122031. http://jaoa.org/article.aspx?articleid=2093199.
«Endoscopic approaches to treatment of achalasia». Therapeutic Advances in Gastroenterology 6 (2): 115–35. March 2013. doi:10.1177/1756283X12468039. PMID 23503707.
«Efficacy of botulinum toxins on bruxism: an evidence-based review». International Dental Journal 62 (1): 1–5. February 2012. doi:10.1111/j.1875-595X.2011.00085.x. PMID 22251031.
«Contemporary management of lower urinary tract disease with botulinum toxin A: a systematic review of botox (onabotulinumtoxinA) and dysport (abobotulinumtoxinA)». European Urology 60 (4): 784–95. October 2011. doi:10.1016/j.eururo.2011.07.001. PMID 21782318.
«Injections of botulinum A toxin for the treatment of anal fissures». The European Journal of Surgery = Acta Chirurgica 168 (12): 720–23. 2002. doi:10.1080/11024150201680030. PMID 15362583.
«Botulinum toxin in the treatment of strabismus. A review of its use and effects». Disability and Rehabilitation 29 (23): 1823–31. December 2007. doi:10.1080/09638280701568189. PMID 18033607.
«Botulinum toxin injections for adults with overactive bladder syndrome». The Cochrane Database of Systematic Reviews (12): CD005493. December 2011. doi:10.1002/14651858.CD005493.pub3. PMID 22161392.
«Change of eye muscle sarcomeres according to eye position». Journal of Pediatric Ophthalmology and Strabismus 31 (2): 85–88. 1994. PMID 8014792.
«Botulinum toxin and sweating». Journal of Neurology, Neurosurgery, and Psychiatry 57 (11): 1437–38. November 1994. doi:10.1136/jnnp.57.11.1437. PMID 7964832. PMC 1073208. https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1994-11_57_11/page/1437.
«Hyperhidrosis: evolving therapies for a well-established phenomenon». Mayo Clinic Proceedings 80 (5): 657–66. May 2005. doi:10.4065/80.5.657. PMID 15887434. https://archive.org/details/sim_mayo-clinic-proceedings_2005-05_80_5/page/657.
«Botulinum toxin injection for facial wrinkles». American Family Physician 90 (3): 168–75. August 2014. PMID 25077722.
«Botulinum Toxin Treatment of Neuropathic Pain». Seminars in Neurology 36 (1): 73–83. February 2016. doi:10.1055/s-0036-1571953. PMID 26866499.
«Botulinum neurotoxin serotype A: a clinical update on non-cosmetic uses». American Journal of Health-System Pharmacy 61 (22 Suppl 6): S11–23. November 2004. doi:10.1093/ajhp/61.suppl_6.S11. PMID 15598005.
«Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases». Journal of the American Academy of Dermatology 53 (3): 407–15. September 2005. doi:10.1016/j.jaad.2005.06.011. PMID 16112345.
«Botulinum neurotoxin detection and differentiation by mass spectrometry». Emerging Infectious Diseases 11 (10): 1578–83. October 2005. doi:10.3201/eid1110.041279. PMID 16318699.
Dressler, D; Saberi, FA; Barbosa, ER (March 2005). «Botulinum toxin: mechanisms of action.». Arquivos de Neuro-Psiquiatria 63 (1): 180–5. doi:10.1159/000083259. PMID 15830090.
«Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication». Molecules 16 (1): 202–20. December 2010. doi:10.3390/molecules16010202. PMID 21193845.
«Historical aspects of botulinum toxin: Justinus Kerner (1786–1862) and the "sausage poison"». Neurology 53 (8): 1850–53. November 1999. doi:10.1212/wnl.53.8.1850. PMID 10563638.
«Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as "Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus" in Zeitschrift für Hygiene und Infektionskrankheiten 26: 1–56, 1897» (στα German). Reviews of Infectious Diseases 1 (4): 701–19. 1979. PMID 399378. Original
doi:10.1007/BF02220526
«The purification and crystallization of Clostridium botulinum type A toxin». Science 103 (2681): 613–14. May 1946. doi:10.1126/science.103.2681.613. PMID 21026141. Bibcode: 1946Sci...103..613L.
«The action of botulinum toxin on the neuro-muscular junction». The Journal of Physiology 109 (1–2): 10–24. August 1949. doi:10.1113/jphysiol.1949.sp004364. PMID 15394302.
«Diagnostic injection of Xylocaine into extraocular muscles». Ophthalmology 89 (5): 489–91. May 1982. doi:10.1016/s0161-6420(82)34764-8. PMID 7099568. https://archive.org/details/sim_ophthalmology_1982-05_89_5/page/489.
«Atrophy of skeletal muscle in chick embryos treated with botulinum toxin». Science 145 (3633): 719–21. August 1964. doi:10.1126/science.145.3633.719. PMID 14163805. Bibcode: 1964Sci...145..719D.
«Pharmacologic weakening of extraocular muscles». Investigative Ophthalmology 12 (12): 924–27. December 1973. PMID 4203467.
«Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery». Ophthalmology 87 (10): 1044–49. October 1980. doi:10.1016/s0161-6420(80)35127-0. PMID 7243198. https://archive.org/details/sim_ophthalmology_1980-10_87_10/page/1044.
«The US Orphan Drug Act: rare disease research stimulator or commercial opportunity?». Health Policy 95 (2–3): 216–28. May 2010. doi:10.1016/j.healthpol.2009.12.001. PMID 20036435.
«Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis». Plastic and Reconstructive Surgery 84 (2): 353–55. August 1989. doi:10.1097/01.prs.0000205566.47797.8d. PMID 2748749.
«Treatment of glabellar frown lines with C. botulinum-A exotoxin». The Journal of Dermatologic Surgery and Oncology 18 (1): 17–21. January 1992. doi:10.1111/j.1524-4725.1992.tb03295.x. PMID 1740562.
«Botulinum toxin A: a novel method to remove periorbital wrinkles». Facial Plastic Surgery 10 (2): 141–46. April 1994. doi:10.1055/s-2008-1064563. PMID 7995530.
«Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study». Otolaryngology–Head and Neck Surgery 123 (6): 669–76. December 2000. doi:10.1067/mhn.2000.110960. PMID 11112955.
«Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis». JAMA 307 (16): 1736–45. April 2012. doi:10.1001/jama.2012.505. PMID 22535858.
«Therapeutic use of botulinum toxin in migraine: mechanisms of action». British Journal of Pharmacology 171 (18): 4177–92. September 2014. doi:10.1111/bph.12763. PMID 24819339.
«Comparison and overview of currently available neurotoxins». The Journal of Clinical and Aesthetic Dermatology 7 (2): 31–39. February 2014. PMID 24587850.
«Properties and use of botulinum toxin and other microbial neurotoxins in medicine». Microbiological Reviews 56 (1): 80–99. March 1992. PMID 1579114.
«Thermal inactivation of type E botulinum toxin». Applied Microbiology 15 (2): 249–56. March 1967. PMID 5339838.
«I will survive: DNA protection in bacterial spores». Trends in Microbiology 15 (4): 172–80. April 2007. doi:10.1016/j.tim.2007.02.004. PMID 17336071.
«Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins». Toxicon 54 (5): 575–82. October 2009. doi:10.1016/j.toxicon.2009.03.016. PMID 19327377. PMC 2730986. https://archive.org/details/sim_toxicon_2009-10_54_5/page/575.
«Injection of type A botulinum toxin into extraocular muscles for correction of strabismus». Canadian Journal of Ophthalmology 22 (4): 212–17. June 1987. PMID 3607594. https://archive.org/details/sim_canadian-journal-of-ophthalmology_1987-06_22_4/page/212.
«Botulinum toxin therapy of eye muscle disorders. Safety and effectiveness. American Academy of Ophthalmology». Ophthalmology Suppl: 37–41. September 1989. doi:10.1016/s0161-6420(89)32989-7. PMID 2779991.
«BOTOX: Broadening the Horizon of Dentistry». Journal of Clinical and Diagnostic Research : JCDR 8 (12): ZE25–9. December 2014. doi:10.7860/JCDR/2014/11624.5341. PMID 25654058.
«Botulinum Toxin for the Treatment of Gummv Smile». The Journal of Contemporary Dental Practice 18 (6): 474–478. June 2017. doi:10.5005/jp-journals-10024-2068. PMID 28621277.
«Surface anatomy of the lip elevator muscles for the treatment of gummy smile using botulinum toxin». The Angle Orthodontist 79 (1): 70–7. January 2009. doi:10.2319/091407-437.1. PMID 19123705.
«Botox and the gummy smile». Progress in Orthodontics 11 (1): 76–82. May 2010. doi:10.1016/j.pio.2010.04.004. PMID 20529632.
«Gummy smile and botulinum toxin: a new approach based on the gingival exposure area». Journal of the American Academy of Dermatology 63 (6): 1042–51. December 2010. doi:10.1016/j.jaad.2010.02.053. PMID 21093661.
«OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program». Headache 50 (6): 921–36. June 2010. doi:10.1111/j.1526-4610.2010.01678.x. PMID 20487038. https://archive.org/details/sim_headache_2010-06_50_6/page/921.
«Botulinum toxin type a for chronic migraine». Current Neurology and Neuroscience Reports 10 (2): 140–46. March 2010. doi:10.1007/s11910-010-0087-5. PMID 20425239.
«Neurotoxins: Expanding Uses of Neuromodulators in Medicine – Major Depressive Disorder». Plastic and Reconstructive Surgery 136 (5 Suppl): 111S–19S. November 2015. doi:10.1097/PRS.0000000000001733. PMID 26441090.

pubmedcentral.nih.gov

«Endoscopic approaches to treatment of achalasia». Therapeutic Advances in Gastroenterology 6 (2): 115–35. March 2013. doi:10.1177/1756283X12468039. PMID 23503707.
«Botulinum toxin and sweating». Journal of Neurology, Neurosurgery, and Psychiatry 57 (11): 1437–38. November 1994. doi:10.1136/jnnp.57.11.1437. PMID 7964832. PMC 1073208. https://archive.org/details/sim_journal-of-neurology-neurosurgery-and-psychiatry_1994-11_57_11/page/1437.
«Botulinum neurotoxin detection and differentiation by mass spectrometry». Emerging Infectious Diseases 11 (10): 1578–83. October 2005. doi:10.3201/eid1110.041279. PMID 16318699.
«Small molecule inhibitors as countermeasures for botulinum neurotoxin intoxication». Molecules 16 (1): 202–20. December 2010. doi:10.3390/molecules16010202. PMID 21193845.
«The action of botulinum toxin on the neuro-muscular junction». The Journal of Physiology 109 (1–2): 10–24. August 1949. doi:10.1113/jphysiol.1949.sp004364. PMID 15394302.
«Therapeutic use of botulinum toxin in migraine: mechanisms of action». British Journal of Pharmacology 171 (18): 4177–92. September 2014. doi:10.1111/bph.12763. PMID 24819339.
«Comparison and overview of currently available neurotoxins». The Journal of Clinical and Aesthetic Dermatology 7 (2): 31–39. February 2014. PMID 24587850.
«Properties and use of botulinum toxin and other microbial neurotoxins in medicine». Microbiological Reviews 56 (1): 80–99. March 1992. PMID 1579114.
«Thermal inactivation of type E botulinum toxin». Applied Microbiology 15 (2): 249–56. March 1967. PMID 5339838.
«Investigations into small molecule non-peptidic inhibitors of the botulinum neurotoxins». Toxicon 54 (5): 575–82. October 2009. doi:10.1016/j.toxicon.2009.03.016. PMID 19327377. PMC 2730986. https://archive.org/details/sim_toxicon_2009-10_54_5/page/575.
«BOTOX: Broadening the Horizon of Dentistry». Journal of Clinical and Diagnostic Research : JCDR 8 (12): ZE25–9. December 2014. doi:10.7860/JCDR/2014/11624.5341. PMID 25654058.

nytimes.com

Boffey, Philip M. (October 14, 1986). «Loss Of Drug Relegates Many To Blindness Again». The New York Times. https://www.nytimes.com/1986/10/14/science/loss-of-drug-relegates-many-to-blindness-again.html. Ανακτήθηκε στις July 14, 2010.

phac-aspc.gc.ca

Clostridium botulinum - Οργανισμός Δημόσιας Υγείας του Καναδά. Phac-aspc.gc.ca (19 Απριλίου 2011). Ανακτήθηκε στις 6 Μαΐου 2012.

shareholder.com

agn.client.shareholder.com

«Allergan Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell-Based Assay for BOTOX and BOTOX Cosmetic (onabotulinumtoxinA)». Allergan. 24 Ιουνίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 26 Ιουνίου 2011. Ανακτήθηκε στις 26 Ιουνίου 2011.

springer.com

adisinsight.springer.com

http://adisinsight.springer.com/drugs/800008810

washingtonpost.com

«In U.S., Few Alternatives To Testing On Animals». Washington Post. 12 Απριλίου 2008. Ανακτήθηκε στις 26 Ιουνίου 2011.

web.archive.org

«Actavis plc is now Allergan plc». Allergan. 15 Ιουνίου 2015. Αρχειοθετήθηκε από το πρωτότυπο στις 5 Μαΐου 2016. Ανακτήθηκε στις 16 Ιουνίου 2015.
«Botox chemical may spread, Health Canada confirms». CBC News. January 13, 2009. Αρχειοθετήθηκε από το πρωτότυπο στις 21 February 2009. https://web.archive.org/web/20090221144310/http://www.cbc.ca/consumer/story/2009/01/13/botox.html.
«Allergan Receives FDA Approval for First-of-Its-Kind, Fully in vitro, Cell-Based Assay for BOTOX and BOTOX Cosmetic (onabotulinumtoxinA)». Allergan. 24 Ιουνίου 2011. Αρχειοθετήθηκε από το πρωτότυπο στις 26 Ιουνίου 2011. Ανακτήθηκε στις 26 Ιουνίου 2011.
Chapman, Paul (10 Μαΐου 2012). «The global botox market forecast to reach $2.9 billion by 2018». Αρχειοθετήθηκε από το πρωτότυπο στις 6 Αυγούστου 2012. Ανακτήθηκε στις 5 Οκτωβρίου 2012.
Koirala, Janak· Basnet, Sangita (14 Ιουλίου 2004). «Botulism, Botulinum Toxin, and Bioterrorism: Review and Update». Medscape. Cliggott Publishing. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Ιουνίου 2011. Ανακτήθηκε στις 14 Ιουλίου 2010.
«Αρχειοθετημένο αντίγραφο». Αρχειοθετήθηκε από το πρωτότυπο στις 18 Ιουνίου 2017. Ανακτήθηκε στις 10 Απριλίου 2019.
Petrou, Ilya (Spring 2009). «Medy-Tox Introduces Neuronox to the Botulinum Toxin Arena» (PDF). The European Aesthetic Guide. Αρχειοθετήθηκε από το πρωτότυπο στις 2013-03-20. https://web.archive.org/web/20130320010107/http://www.miinews.com/pdf/MedyTox_Ed_EAGsp09v2_022809.pdf#. Ανακτήθηκε στις 2009-12-09.
Watkins, Tom (October 15, 2010). «FDA approves Botox as migraine preventative». CNN (US). Αρχειοθετήθηκε από το πρωτότυπο στις 2020-07-27. https://web.archive.org/web/20200727025543/http://us.cnn.com/2010/HEALTH/10/15/migraines.botox/index.html. Ανακτήθηκε στις 2019-04-10.

webmd.com

«FDA Approves Botox to Treat Chronic Migraines». WebMD. http://www.webmd.com/migraines-headaches/news/20101018/fda-approves-botox-to-treat-chronic-migraines#1. Ανακτήθηκε στις 12 May 2017.

who.int

«Fact Sheet: Botulism». World Health Organization. Ανακτήθηκε στις 4 Οκτωβρίου 2016.